Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Acquired blood mutations cause acute kidney injury via dysregulated inflammation

Acute kidney injury affects one in five hospitalized patients and can lead to lasting kidney damage or death. We show that clonal hematopoiesis of indeterminate potential — a common age-related condition caused by blood cell mutations — increases the risk of acute kidney injury in multiple cohorts of human patients and in mouse models.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: CHIP is associated with AKI and enhanced infiltration of inflammatory macrophages in the kidney parenchyma.

References

  1. Bhatraju, P. K. et al. Association between early recovery of kidney function after acute kidney injury and long-term clinical outcomes. JAMA Netw. Open 3, e202682–e202682 (2020). This paper reports on longitudinal outcomes of the ASSESS-AKI study, which followed patients with AKI for up to 5 years.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse out-comes. N. Engl. J. Med. 371, 2488–2498 (2014). This paper reports an association among CHIP, cardiovascular disease and mortality.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Vlasschaert, C. et al. Association of clonal hematopoiesis of indeterminate potential with worse kidney function and anemia in two cohorts of patients with advanced chronic kidney disease. J. Am. Soc. Nephrol. 33, 985–995 (2022). This paper reports an association between CHIP and a decline in kidney function among people with chronic kidney disease.

  4. Kestenbaum, B. et al. Clonal hematopoiesis of indeterminate potential and kidney function decline in the general population. Am. J. Kidney Dis. 81, 329–335 (2023). This paper reports an association between CHIP and a decline in kidney function in the general population.

  5. Vlasschaert, C., Lanktree, M. B., Rauh, M. J., Kelly, T. N. & Natarajan, P. Clonal haematopoiesis, ageing and kidney disease. Nat. Rev. Nephrol. 20, 161–174 (2023). This review article highlights the direct and indirect effects of CHIP on kidney health, including its effects on renal function, cardiovascular disease and metabolic diseases that affect the kidney, such as diabetes and obesity.

    Article  PubMed  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Vlasschaert, C. et al. Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury. Nat. Med. https://doi.org/10.1038/s41591-024-02854-6 (2024).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acquired blood mutations cause acute kidney injury via dysregulated inflammation. Nat Med 30, 646–647 (2024). https://doi.org/10.1038/s41591-024-02861-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-024-02861-7

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing